AD
Basaglar(CAS: 160337-95-1)
CAS Number
Related Products
Acarbose EP Impurity C
CAS Number: 610271-07-3
Cyclosporin D
CAS Number: 63775-96-2
Chloroeremomycin
CAS Number: 118395-73-6
Cyclosporin A
CAS Number: 59865-13-3
![(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-Allyl-1,14-dihydroxy-12-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-propen-2-yl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatr
icyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone](https://static.chemtradehub.com/structs/104/104987-11-3-db06.webp)
Aureobasidin A
CAS Number: 127785-64-2
(2R,4E)-2-Methyl-4-hexenoic acid
CAS Number: 93553-73-2
2'-Deoxy-2'-fluoroguanosine
CAS Number: 78842-13-4
Other Suppliers for Basaglar
Basic Information
Molecular Formula
C267H404N72O78S2
Molecular Weight
6063 g/mol
Chemical Identifiers
SMILES
CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NCC(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN
InChIKey
COCFEDIXXNGUNL-RFKWWTKHSA-N
Database References
FAQ
Basaglar (CAS: 160337-95-1) is subject to the Global Harmonized System (GHS) for classification and labeling of chemicals, REACH regulations for European markets, and FDA/EPA guidelines for pharmaceutical and chemical applications. Manufacturers must comply with these regulations for safety data sheets, labeling, and environmental handling.
While Basaglar (CAS: 160337-95-1) is a specific compound, in synthesis, alternatives like glargine, insulin detemir, and insulin glulisine can be considered. These alternatives may offer similar properties but with different chemical structures and synthesis methods.
The market for Basaglar (CAS: 160337-95-1) is growing due to its long-lasting effects in managing blood glucose levels. Research trends focus on improving formulations, understanding long-term safety, and exploring combination therapies. The market is expected to expand with increasing diabetes prevalence and advancements in insulin delivery systems.
Waste containing Basaglar (CAS: 160337-95-1) should be collected in appropriate containers and disposed of through regulated medical waste channels. This includes incineration or professional waste disposal services to ensure safety and compliance with environmental regulations. Proper labeling and documentation are required for safe transportation and disposal.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Mr. Zhu
81939905@qq.com